Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
Details for 2018739593
Up to date per 04.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2018739593
Title / Product Name
VERWENDUNG VON CLADRIBIN ZUR BEHANDLUNG AUTOIMMUNER NEUROMUSKULÄRER ERKRANKUNGEN
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2018739593
EP Publication Number
3654989
E-Number
1646123
Language
EN
PCT Number
GB18051801
Publication Date
27.05.2020 A
03.01.2024 B1
Registration Date
03.01.2024
AT Publication Date
15.01.2024
Application Date
28.06.2018
Registration Number
-
Priorities
21.07.2017
GB
201711800
IPC
A61K 31/7076 20060101AFI20190125BHEP
Maximum Duration of Protection
28.06.2038
Owner
Chord Therapeutics SA
c/o ARES TRADING SA Terre Bonne Business Park Route de Crassier 1
1262 Eysins
CH
Representative
Representative
Puchberger & Partner Patentanwälte
Reichsratsstraße 13
1010 Wien
AT
Inventor
REJDAK, Konrad
Organowa 3/20
20-882 Lublin
PL
Information about Fees
Click here to load the fees